PULM - Pulmatrix Inc logo

PULM

Pulmatrix Inc

Pulmatrix, Inc. develops inhaled therapeutic products for migraine and respiratory diseases. Its iSPERSE platform delivers small or large molecules to the lungs, while its pipeline includes treatments for chronic obstructive pulmonary disease and asthma.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$4today

Score Overview

1 Year
Scoreโ€”
Net Growth12.32%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score6.7
Net Growth77.56%
Net TrendEvery year
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth83.74%
Net Trend70%
Net Income Consistency
Rev Growth-100.00%
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth81.25%
Net Trend58%
Net Income Consistency
Rev Growth-100.00%
Rev Trend50%
Revenue Consistency

See the full market ranking โ†’

Pulmatrix Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 12M to $ 0.00 and net income went from -$ 19M to -$ 5M. Revenue increased in 3 of those 5 years; net income in every one.

Between 2015 and 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 26M to -$ 5M. Revenue increased in 5 of those 10 years; net income in 7.

Pulmatrix Inc currently holds a 5-year HDB Score of 6.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.60โ€”
1 Year2025-08-12
$ 5.00-67.98%
5 Years2021-08-12
$ 16.34-90.21%
10 Years2016-08-12
$ 392.00-99.59%
All Time2014-03-21
$ 3.63K-99.96%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 4M$ 3M
2025$ 0.00-$ 5M$ 4M
2024$ 7M-$ 9M$ 9M
2023$ 7M-$ 14M$ 19M
2022$ 6M-$ 18M$ 35M
2021$ 5M-$ 20M$ 53M
2020$ 12M-$ 19M$ 31M
2019$ 7M-$ 20M$ 23M
2018$ 153K-$ 20M$ 2M
2017$ 335K-$ 18M$ 3M
2016$ 835K-$ 27M$ 4M
2015$ 1M-$ 26M$ 18M
IPO2014$ 352K-$ 24M$ 15M

Explore beyond PULM

You're looking at Pulmatrix Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies